Companies / Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc.

Nasdaq: SNOACIK 1367083BOULDER, CO

Financials · FY2026

Revenue$19.53M
Net income$-3.17M
Total debt$155.0K
Cash$5.34M
Diluted EPS$-1.89
Shares outstanding4.8M

Ownership

4.8M shares outstanding · as of Aug 6, 2026
2.4%Institutions
Ownership
Institutions2.36%112,947
Public float97.64%4,675,478

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Dvonch Jerome JChief Financial Officer
Trombly Amy MossCEOChief Executive Officer

Institutional holders 16

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 2, 2026Dal Poggetto John
Executive
GrantRestricted Stock Units+5K
+24.69%
25,250
0.53% of shares
low
Jan 2, 2026Weigerstorfer Philippe
Director
GrantStock option (right to buy)+10K
+99.99%
20,001
0.42% of shares
low
Jan 2, 2026Dvonch Jerome J
Executive
GrantRestricted Stock Units+5K
+17.01%
34,391
0.72% of shares
low
Jan 2, 2026Birnbaum Jay E
Director
GrantStock option (right to buy)+10K
+99.99%
20,001
0.42% of shares
low
Jan 2, 2026Trombly Amy Moss
CEO
GrantRestricted Stock Units+10K
+31.07%
42,185
0.88% of shares
low
Jan 2, 2026McLaughlin John
Director
GrantStock option (right to buy)+10K
+99.99%
20,001
0.42% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SNOACommon StockEquity83558L303BBG000M75YR0